ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q4Scopus Q3SCImago #9,861Hybrid

Journal of Neurovirology

Acronym:njiv
•
Abbreviation (ISO):J. NEUROVIROL
•
Identifier (ISSN):1355-0284(Print)/1538-2443(Online)
•
Publisher:Springer International Publishing
Clarivate IF (2026)
2↑ +0.1
Journal Impact Factor
IF Trend↓
WoS Quartile
Q4
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Journal of Neurovirology

WoS Q4
12453.2320182.320192.3520202.6420213.7420223.220232.320241.9202522026
Annual Impact Factor Metric
Current (2026):2
Scopus SJR & RankScopus Q3
0.6
#9,861

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
101

101 papers with at least that number of citations each

WoS: SCIE / JCRQ4
Self-Citation Rate4.3%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
112articles/year
31.14% Gold OA•91.18% Original Research

Aims & Scope

The Journal of NeuroVirology (JNV) provides a unique platform for the publication of high-quality basic science and clinical studies on the molecular biology and pathogenesis of viral infections of the nervous system, and for reporting on the development of novel therapeutic strategies using neurotropic viral vectors. The Journal also emphasizes publication of non-viral infections that affect the central nervous system. The Journal publishes original research articles, reviews, case reports, coverage of various scientific meetings, along with supplements and special issues on selected subjects. The Journal is currently accepting submissions of original work from the following basic and clinical research areas: Aging & Neurodegeneration, Apoptosis, CNS Signal Transduction, Emerging CNS Infections, Molecular Virology, Neural-Immune Interaction, Novel Diagnostics, Novel Therapeutics, Stem Cell Biology, Transmissable Encephalopathies/Prion, Vaccine Development, Viral Genomics, Viral Neurooncology, Viral Neurochemistry, Viral Neuroimmunology, Viral Neuropharmacology.

Topics Covered (Recognized by AI)
Medicine98.3%Biology98.1%Immunology81%Genetics78.2%Internal medicine75.5%Virology74.5%Psychology73.8%Neuroscience65.8%Pathology57.5%Virus56.3%Psychiatry56.3%Chemistry49.3%Biochemistry48.3%Endocrinology32.3%Family medicine32.1%Human immunodeficiency virus (HIV)32%Disease30.4%Gene28.4%Neurology25.8%Central nervous system20.9%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

NEUROSCIENCES

Q4
Rank257/330
IndexSCIE
JCRSCIE2026

VIROLOGY

Q3
Rank31/44
IndexSCIE
JCISCIE2026

NEUROSCIENCES

Q4
Rank266/330
IndexSCIE
JCISCIE2026

VIROLOGY

Q3
Rank29/44
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF2
Articles / Year47
Total Citations7
2025
IF1.9
Articles / Year49
Total Citations84
2024
IF2.3
Articles / Year53
Total Citations231
2023
IF3.2
Articles / Year79
Total Citations531
2022
IF3.739
Articles / Year74
Total Citations596

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #9,861Scopus Q3SCImago Profile
Scopus Coverage:1995-2026
Scopus Broad Areas:Immunology and MicrobiologyMedicineNeuroscience
Scopus Citation Rank (SJR)Q3
0.6

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q3
Citations / Doc (2 years)
1.97

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,111 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations380
3-Year Documents204
Citable Documents199

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)1

Citations in government and international policy documents

Female Author Rate45.4%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

NeurologyQ3
Neurology (clinical)Q3
VirologyQ3
Cellular and Molecular NeuroscienceQ4
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 4.3%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区NEUROSCIENCES
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Journal of Neurovirology (acronym: njiv, abbr: J. NEUROVIROL, ISSN: 1355-0284) is a peer-reviewed international scholarly journal in the field of Medicine, published by Springer International Publishing in United States since 2001. The periodical holds a Journal Impact Factor (JIF) of 2.00, ranking in quartile Q4 of Web of Science (SCIE), a Scopus SJR indicator of 0.600 (Q3), an H-index of 101.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 112 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,111 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Springer International Publishing
Publication Language
English
Frequency
Bimonthly
Founding Year
2001
Indexing & Databases
SCIEScopusPubMed
Editorial Address
TAYLOR & FRANCIS INC, 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, USA, PA, 19106

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 8872eb1a-8884-46b3-b9e1-f7a87cc94387
Database Updated: 2026-10-01